Drugs Affecting Lipid Metabolism: Risk Factors And Future Directions
Condition: SECONDHAND
This is a secondhand book. The jacket image is a photograph of the exact copy we have in stock. This image shows the condition of this book. Further condition remarks are below.
Condition remarks:
Book: Good
Jacket: No dust jacket - cloth/board in good condition
Pages: Good
Markings: Previous owner
Condition remarks: minor stains on the book block
At the crossroads of pharmacology and cardiovascular science, Drugs Affecting Lipid Metabolism: Risk Factors and Future Directions stands as an authoritative compendium examining the complex relationship between therapeutic agents and lipid metabolism. Edited by a distinguished international team of medical scientists — including A.M. Gotto Jr. from Baylor College of Medicine in Houston and R. Paoletti from the Institute of Pharmacological Sciences in Milan — this volume chronicles the latest advances in lipid-modifying drug therapies, presenting a rigorous analysis of cardiovascular risk factors and the pharmacological strategies designed to address them. The work draws together leading voices from both North American and European research institutions, reflecting the truly global nature of the scientific effort to combat lipid-related disease. It argues persuasively for a forward-looking approach to pharmacotherapy, detailing emerging directions in drug development and the clinical management of dyslipidaemia. Published by Kluwer Academic Publishers — a trusted name in specialist medical and scientific literature — this essential reference illuminates the evolving landscape of lipid metabolism research and leaves the reader questioning just how far future therapeutics may yet transform cardiovascular medicine.
Author: A.M. Gotto, Jr., R. Paoletti, L.C. Smith, A.L. Catapano, A.S. Jackson
Format: Hardback
Published: 1996, Kluwer Academic Publishers
Genre: Medicine
Condition remarks:
Book: Good
Jacket: No dust jacket - cloth/board in good condition
Pages: Good
Markings: Previous owner
Condition remarks: minor stains on the book block
At the crossroads of pharmacology and cardiovascular science, Drugs Affecting Lipid Metabolism: Risk Factors and Future Directions stands as an authoritative compendium examining the complex relationship between therapeutic agents and lipid metabolism. Edited by a distinguished international team of medical scientists — including A.M. Gotto Jr. from Baylor College of Medicine in Houston and R. Paoletti from the Institute of Pharmacological Sciences in Milan — this volume chronicles the latest advances in lipid-modifying drug therapies, presenting a rigorous analysis of cardiovascular risk factors and the pharmacological strategies designed to address them. The work draws together leading voices from both North American and European research institutions, reflecting the truly global nature of the scientific effort to combat lipid-related disease. It argues persuasively for a forward-looking approach to pharmacotherapy, detailing emerging directions in drug development and the clinical management of dyslipidaemia. Published by Kluwer Academic Publishers — a trusted name in specialist medical and scientific literature — this essential reference illuminates the evolving landscape of lipid metabolism research and leaves the reader questioning just how far future therapeutics may yet transform cardiovascular medicine.